VERSANT VENTURE CAPITAL VI, L.P. sold 10.8% of their position (191.38K shares) of LENZ THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.51M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/14/2025ACC: 0000950170-25-095616
10% Owner
Since Jun 2021
-191.38K
Net shares
Net seller
$6.51M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
191.38K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−191.38K
Price / share
$34.00
Trade value
$6.51M
% of position
10.8%
7/10/2025
1.77M→1.58M
Total
Net shares
−191.38K
Net value
-$6.51M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/10/2025 | S · Sale | −191.38K | $34.00 | $6.51M | 10.8% | 1.77M | 1.58M |
| Total | −191.38K | -$6.51M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.05M
Common Stock
IndirectShares owned842.16K
Total
1.89M indirect1.89M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.05M | Indirect |
| Common Stock | 842.16K | Indirect |
| Total | 1.89M | 1.89M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported